Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Carter

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Pharmaceutical Sciences|July 1, 1990
Quantitative structure-activity relationships of inhibitors of immune complex-induced inflammation: 1-phenyl-3-aminopyrazoline derivativesK H Kim, Y C Martin, B Norris, et al.
Inflammation|March 1, 1984
Granulocyte response to oxidized FMLP. Evidence for partial inactivation of FMLPK Van Dyke, V Castranova, C J Van Dyke, et al.
Shock (Augusta, Ga.)|April 1, 1996
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonistK T Kruse-Elliott, D H Albert, J B Summers, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonistD H Albert, T J Magoc, H D Kleinert, et al.
Journal of Medicinal Chemistry|July 1, 1991
4-hydroxythiazole inhibitors of 5-lipoxygenaseF A Kerdesky, J H Holms, J L Moore, et al.
Biochemical and Biophysical Research Communications|January 17, 1995
Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cellsM Nakane, J S Pollock, V Klinghofer, et al.
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.
Molecular Pharmacology|April 1, 1995
Novel potent and selective inhibitors of inducible nitric oxide synthaseM Nakane, V Klinghofer, J E Kuk, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1984
Heinz bodies, methemoglobinemia, and hemolytic anemia induced in rats by 3-amino-1-[m-(trifluoromethyl)phenyl]-2-pyrazolineF L Fort, M C Pratt, G W Carter, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Preclinical and clinical activity of zileuton and A-78773R L Bell, C Lanni, P E Malo, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|July 1, 1990
Quantitative structure-activity relationships of inhibitors of immune complex-induced inflammation: 1-phenyl-3-aminopyrazoline derivativesK H Kim, Y C Martin, B Norris, et al.
Inflammation|March 1, 1984
Granulocyte response to oxidized FMLP. Evidence for partial inactivation of FMLPK Van Dyke, V Castranova, C J Van Dyke, et al.
Shock (Augusta, Ga.)|April 1, 1996
Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonistK T Kruse-Elliott, D H Albert, J B Summers, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonistD H Albert, T J Magoc, H D Kleinert, et al.
Journal of Medicinal Chemistry|July 1, 1991
4-hydroxythiazole inhibitors of 5-lipoxygenaseF A Kerdesky, J H Holms, J L Moore, et al.
Biochemical and Biophysical Research Communications|January 17, 1995
Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cellsM Nakane, J S Pollock, V Klinghofer, et al.
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.
Molecular Pharmacology|April 1, 1995
Novel potent and selective inhibitors of inducible nitric oxide synthaseM Nakane, V Klinghofer, J E Kuk, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1984
Heinz bodies, methemoglobinemia, and hemolytic anemia induced in rats by 3-amino-1-[m-(trifluoromethyl)phenyl]-2-pyrazolineF L Fort, M C Pratt, G W Carter, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Preclinical and clinical activity of zileuton and A-78773R L Bell, C Lanni, P E Malo, et al.
Pageof 8